Cargando…
Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455–464
Autores principales: | Mita, Tomoya, Katakami, Naoto, Shiraiwa, Toshihiko, Yoshii, Hidenori, Onuma, Tomio, Kuribayashi, Nobuichi, Osonoi, Takeshi, Kaneto, Hideaki, Kosugi, Keisuke, Umayahara, Yutaka, Yamamoto, Tsunehiko, Matsumoto, Kazunari, Yokoyama, Hiroki, Tsugawa, Mamiko, Gosho, Masahiko, Shimomura, Iichiro, Watada, Hirotaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439411/ https://www.ncbi.nlm.nih.gov/pubmed/28420697 http://dx.doi.org/10.2337/dc17-er06a |
Ejemplares similares
-
Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE)
por: Mita, Tomoya, et al.
Publicado: (2014) -
The Effect of Sitagliptin on the Regression of Carotid Intima-Media Thickening in Patients with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the Sitagliptin Preventive Study of Intima-Media Thickness Evaluation
por: Mita, Tomoya, et al.
Publicado: (2017) -
Changes in carotid intima‐media thickening in patients with type 2 diabetes mellitus: Subanalysis of the Sitagliptin Preventive Study of Intima‐Media Thickness Evaluation
por: Mita, Tomoya, et al.
Publicado: (2017) -
Effect of sitagliptin on tissue characteristics of the carotid wall in patients with type 2 diabetes: a post hoc sub-analysis of the sitagliptin preventive study of intima-media thickness evaluation (SPIKE)
por: Katakami, Naoto, et al.
Publicado: (2018) -
Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39:139–148
por: Mita, Tomoya, et al.
Publicado: (2017)